JP2006500321A5 - - Google Patents

Download PDF

Info

Publication number
JP2006500321A5
JP2006500321A5 JP2004503504A JP2004503504A JP2006500321A5 JP 2006500321 A5 JP2006500321 A5 JP 2006500321A5 JP 2004503504 A JP2004503504 A JP 2004503504A JP 2004503504 A JP2004503504 A JP 2004503504A JP 2006500321 A5 JP2006500321 A5 JP 2006500321A5
Authority
JP
Japan
Prior art keywords
lactalbumin
variant
biologically active
use according
mutation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004503504A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006500321A (ja
Filing date
Publication date
Priority claimed from GBGB0210464.4A external-priority patent/GB0210464D0/en
Application filed filed Critical
Publication of JP2006500321A publication Critical patent/JP2006500321A/ja
Publication of JP2006500321A5 publication Critical patent/JP2006500321A5/ja
Pending legal-status Critical Current

Links

JP2004503504A 2002-05-08 2003-05-08 α−ラクトアルブミン(HAMLET)および補因子の活性複合体 Pending JP2006500321A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0210464.4A GB0210464D0 (en) 2002-05-08 2002-05-08 Therapeutic treatment
PCT/IB2003/002366 WO2003095490A1 (en) 2002-05-08 2003-05-08 Active complex of alpha-lactalbumin (hamlet) and cofactor

Publications (2)

Publication Number Publication Date
JP2006500321A JP2006500321A (ja) 2006-01-05
JP2006500321A5 true JP2006500321A5 (https=) 2006-06-22

Family

ID=9936230

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004503504A Pending JP2006500321A (ja) 2002-05-08 2003-05-08 α−ラクトアルブミン(HAMLET)および補因子の活性複合体

Country Status (8)

Country Link
US (2) US7270822B2 (https=)
EP (1) EP1506233B8 (https=)
JP (1) JP2006500321A (https=)
AU (1) AU2003233116B2 (https=)
CA (1) CA2485223A1 (https=)
DK (1) DK1506233T3 (https=)
GB (1) GB0210464D0 (https=)
WO (1) WO2003095490A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210464D0 (en) 2002-05-08 2002-06-12 Svanborg Catharina Therapeutic treatment
JP2007524708A (ja) * 2004-02-26 2007-08-30 ハムレット・ファルマ・アーベー 血管新生を阻害するラクトアルブミン
GB0408752D0 (en) * 2004-04-20 2004-05-26 Hamlet Ltd Therapeutic treatment
EP1715334A1 (fr) * 2005-04-22 2006-10-25 Adamant Technologies SA Procédé utilisant un capteur électrochimique et électrodes formant ce capteur
GB0518720D0 (en) * 2005-09-14 2005-10-19 Hamlet Pharma Ab Therapeutic combination
WO2009135494A2 (en) * 2008-05-09 2009-11-12 Nya Hamlet Pharma Ab Alpha-lactalbumin composition for the treatment of actinic keratosis
WO2010131237A1 (en) * 2009-05-13 2010-11-18 Agriculture And Food Development Authority (Teagasc) A process for producing a biologically active globular protein complex
US11471497B1 (en) 2019-03-13 2022-10-18 David Gordon Bermudes Copper chelation therapeutics

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4348376A (en) * 1980-03-03 1982-09-07 Goldenberg Milton David Tumor localization and therapy with labeled anti-CEA antibody
JP2961625B2 (ja) 1991-01-21 1999-10-12 雪印乳業株式会社 α−ラクトアルブミン含有量の高い組成物の製造方法
US6455673B1 (en) * 1994-06-08 2002-09-24 President And Fellows Of Harvard College Multi-mutant diphtheria toxin vaccines
AU7792294A (en) 1994-08-16 1996-03-07 Hemant Sabharwal Antibacterial composition containing multimeric alpha-lactalbumin
US6159748A (en) 1995-03-13 2000-12-12 Affinitech, Ltd Evaluation of autoimmune diseases using a multiple parameter latex bead suspension and flow cytometry
US5614191A (en) * 1995-03-15 1997-03-25 The United States Of America As Represented By The Department Of Health And Human Services IL-13 receptor specific chimeric proteins and uses thereof
DK1032596T3 (da) 1997-11-21 2007-09-10 Nya Hamlet Pharma Ab Fremgangsmåde til fremstilling af lactalbumin
GB9725126D0 (en) * 1997-11-27 1998-01-28 Svanborg Catharina Therapeutic agents
EP1311288A1 (en) 2000-01-20 2003-05-21 Ottawa Health Research Institute Immunostimulatory nucleic acids for inducing a th2 immune response
EP1268534A2 (en) 2000-03-24 2003-01-02 Filgen Biosciences, Inc. Peptides binding to non-acetylated h3 and h4 histones for cancer therapy
EP2206720A1 (en) 2000-04-12 2010-07-14 Human Genome Sciences, Inc. Albumin fusion proteins
GB0205347D0 (en) * 2002-03-07 2002-04-24 Svanborg Catharina Biologically active complex
GB0210464D0 (en) * 2002-05-08 2002-06-12 Svanborg Catharina Therapeutic treatment
JP2007524708A (ja) * 2004-02-26 2007-08-30 ハムレット・ファルマ・アーベー 血管新生を阻害するラクトアルブミン

Similar Documents

Publication Publication Date Title
ES2215940T5 (es) Traccion proteica basica derivada de la leche como agente para reducir la hipertension.
Patil et al. Food protein-derived bioactive peptides in management of type 2 diabetes
US5932259A (en) Bone reinforcing agent and foods and drinks product containing the same
Sun et al. Food protein-derived calcium chelating peptides: A review
ES2529237T3 (es) Hidrolizados de proteínas de la leche con potencial inmunogénico reducido
CN1468108A (zh) 衍生自乳的骨保健组合物
CY1110497T1 (el) Χρηση ενωσης που περιεχει ιωδιο για την παραγωγη ιωδιομενων τροφιμων για να αποφευχθουν παθησεις που προκαλουνται απο δυσλειτουργια του θυρεοειδους αδενα
JP2006500321A5 (https=)
US7713533B2 (en) Active complex of α-lactalbumin (HAMLET) and cofactor
JP2005530703A5 (https=)
CN1771051A (zh) 皮肤胶原产生促进剂
JP2007524708A5 (https=)
CN101842026B (zh) 骨强化用食品原材料
PT2208735E (pt) Matéria alimentar para promover a diferenciação de osteoblasto e inibir a diferenciação de osteoclasto
ATE344325T1 (de) Neisseria lactoferrin-bindendes protein
JP2007533728A5 (https=)
JP4034516B2 (ja) 脂質代謝改善剤
WO2003007793A3 (en) Compositions, methods, and kits related to treating and diagnosing hypertension
WO2012102100A1 (ja) 感覚改善剤
JP2002212096A (ja) 血圧降下剤
JP2927076B2 (ja) 新規タンパク食品素材
JP2007000094A (ja) 鉄添加ホエータンパク質濃縮物およびその製造法
Hussein et al. Effect of enzymatic modification on the biological activity and nutritive value of cow and buffalo casein
Patil et al. Milk-derived Bioactive Peptides: Health Benefits
Zhang Isolation of lactoferrin from bovine colostrum by chromatographic techniques